Paris, France

Bernadette Chappert

This inventor holds 4 USPTO granted patents. Top assignees: Hoechst Marion Roussel, Roussel Uclaf. Active years: 1998-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bernadette Chappert

Introduction

Bernadette Chappert is a notable inventor based in Paris, France. She has made significant contributions to the field of chemistry, particularly in the development of novel compounds. With a total of 4 patents to her name, her work has had a meaningful impact on various applications in the pharmaceutical industry.

Latest Patents

One of her latest patents involves tricyclic compounds, specifically focusing on novel tricyclic compounds of formula I as defined in the specification. This patent outlines a process for their preparation and their use for the preparation of optically active or racemic colchicine and thiocolchicine derivatives. Another significant patent pertains to 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, which details their preparation.

Career Highlights

Throughout her career, Bernadette has worked with prominent companies such as Hoechst Marion Roussel and Roussel Uclaf. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Bernadette has collaborated with esteemed colleagues, including Christian Marie and Edmond Toromanoff. These partnerships have further enriched her work and expanded the scope of her inventions.

Conclusion

Bernadette Chappert's innovative work and her contributions to the field of chemistry exemplify the importance of research and development in creating new solutions. Her patents reflect her dedication to advancing scientific knowledge and improving pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…